These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1828737

  • 1. Increased erythrocyte aldose reductase activity in type 1 diabetic patients.
    Hamada Y, Kito R, Raskin P.
    Diabet Med; 1991 Apr; 8(3):226-31. PubMed ID: 1828737
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte.
    Das B, Srivastava SK.
    Arch Biochem Biophys; 1985 May 01; 238(2):670-9. PubMed ID: 3922304
    [Abstract] [Full Text] [Related]

  • 8. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T, Saito Y, Kawakami M, Yamada N, Sekino H, Hasegawa S, Fidarestat Clinical Pharmacology Study Group.
    J Diabetes Complications; 2004 May 01; 18(6):336-42. PubMed ID: 15531183
    [Abstract] [Full Text] [Related]

  • 9. Influence of interindividual variability of aldose reductase protein content on polyol-pathway metabolites and redox state in erythrocytes in diabetic patients.
    Hamada Y, Nishimura C, Koh N, Sakakibara F, Nakamura J, Tanimoto T, Hotta N.
    Diabetes Care; 1998 Jun 01; 21(6):1014-8. PubMed ID: 9614624
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK, Hair GA, Das B.
    Proc Natl Acad Sci U S A; 1985 Nov 01; 82(21):7222-6. PubMed ID: 3933003
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Localization, isolation and properties of three NADPH-dependent aldehyde reducing enzymes from dog kidney.
    Ohta M, Tanimoto T, Tanaka A.
    Biochim Biophys Acta; 1991 Jul 12; 1078(3):395-403. PubMed ID: 1907200
    [Abstract] [Full Text] [Related]

  • 15. Activation of erythrocyte aldose reductase in man in response to glycaemic challenge.
    Lyons PA, Gould S, Wise PH, Palmer TN.
    Diabetes Res Clin Pract; 1991 Oct 12; 14(1):9-13. PubMed ID: 1748066
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Two forms of aldose reductase in erythrocytes from patients with insulin-dependent diabetes mellitus].
    Shono NI, Rabinovich SE, Platonova LV, Diuzheva TG.
    Vopr Med Khim; 1994 Oct 12; 40(5):45-8. PubMed ID: 7839671
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.